MedTrace Logo

Effect of 6-week Strawberry Supplementation on Insulin Action (STR2)

NCT01457612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2023-02-08

No results posted yet for this study

Summary

The primary study objective is to investigate the potential chronic beneficial effect of polyphenolics derived from strawberry on impaired insulin signaling in insulin resistant individuals through their ability to modulate oxidative- and inflammatory-markers that lead to devastating disease, including, but not limited to, diabetes and cardiovascular disease.

Conditions

Interventions

DIETARY_SUPPLEMENT

Strawberry

20g twice per day (BID) in beverage

DIETARY_SUPPLEMENT

Placebo1

Placebo Beverage 1 without fiber

DIETARY_SUPPLEMENT

Placebo2

Placebo Beverage 2 with Fiber

Sponsors & Collaborators

  • California Strawberry Commission

    collaborator OTHER

  • Clinical Nutrition Research Center, Illinois Institute of Technology

    lead INDUSTRY

Principal Investigators

  • Indika Edirisinghe, Ph.D · Institute for Food Safety and Health

  • Britt Burton-Freeman, Ph.D · Institute for Food Safety and Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-01
Primary Completion
2012-12-01
Completion
2013-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01457612 on ClinicalTrials.gov